Optimal dose distribution for eradication of heterogeneous tumours.

The traditional single hit multitarget theory has been applied on the probability of eradication of an organ or a tumor and the probability for causing complications in normal tissue. This simple theory predicts a decreasing possibility to achieve uncomplicated tumor control with increasing tumor size and maintained irradiation technique, because the control curve moves to higher doses and the complication curve to lower doses as the tumor size increases. This simple result is shown to be consistent with clinically observed dose response relations for small and large tumors. The optimal dose distribution for eradication of a heterogeneous tumor is derived on the assumption that a uniform minimal recurrence probability is most advantageous for the patient. The optimal dose distribution is proportional to the spatial variation of the local D0 value and the logarithm of the tumor cell density. Various techniques to measure the density of tumor cells and the different possibilities to deliver non-uniform dose distributions to the target volume are also discussed.

[1]  J. Ovadia,et al.  Isodose distribution and treatment planning with electrons of 20-35 mev. for deep-seated tumors. , 1960, The American journal of roentgenology, radium therapy, and nuclear medicine.

[2]  T. R. Munro,et al.  The relation between tumour lethal doses and the radiosensitivity of tumour cells. , 1961, The British journal of radiology.

[3]  K. G. Zimmer Studies on Quantitative Radiation Biology , 1963 .

[4]  Cornelius A. Tobias,et al.  CHAPTER 4 – Cellular Radiation Biology , 1974 .

[5]  E. H. Porter The statistics of dose/cure relationships for irradiated tumours. Part I. , 1980, The British journal of radiology.

[6]  D. Pressman The development and use of radiolabeled antitumor antibodies. , 1980, Cancer research.

[7]  H Svensson,et al.  Electron and photon beams from a 50 MeV racetrack microtron. , 1980, Acta Radiologica Oncology.

[8]  Effects of single-dose irradiation in tumor blood flow studied by 15O decay after proton activation in situ. , 1981, Radiology.

[9]  C E Metz,et al.  Maximum likelihood estimation of dose-response parameters for therapeutic operating characteristic (TOC) analysis of carcinoma of the nasopharynx. , 1982, International journal of radiation oncology, biology, physics.

[10]  J. Moore,et al.  Dose-incidence curves for tumour control and normal tissue injury, in relation to the response of clonogenic cells. , 1983, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  T E Schultheiss,et al.  Models in radiotherapy: volume effects. , 1983, Medical physics.

[12]  B. Nordell,et al.  Computer assisted dosimetry of scanned electron and photon beams for radiation therapy. , 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  A B Wolbarst,et al.  Optimization of radiation therapy II: the critical-voxel model. , 1984, International journal of radiation oncology, biology, physics.

[14]  A. Wambersie Quality assurance in radiation therapy with special reference to the situation in Europe , 1984 .

[15]  A Brahme,et al.  Dosimetric precision requirements in radiation therapy. , 1984, Acta radiologica. Oncology.

[16]  C A Tobias,et al.  The repair-misrepair model in radiobiology: comparison to other models. , 1985, Radiation research. Supplement.

[17]  L. Peters,et al.  Potential methods for predicting tumor radiocurability. , 1986, International journal of radiation oncology, biology, physics.

[18]  H. Pinedo,et al.  Monoclonal antibodies in cancer treatment: where do we stand after 10 years? , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  A. Brahme,et al.  Optimization of stationary and moving beam radiation therapy techniques. , 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  Anders Brahme Optimal setting of multileaf collimators in stationary beam radiation therapy. , 1988, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].